Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2430
H.R.2430: FDA Reauthorization Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 16, 2017
- Latest Major Action Aug. 18, 2017
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
3 (2 Democrats, 1 Republican)
Bill Versions
- Placed on Calendar Senate - July 17, 2017
- Engrossed in House - July 12, 2017
- Reported in House - July 11, 2017
- Introduced in House - May 16, 2017
When this bill was on the Most Viewed List on Congress.gov
| Week Ending | Rank |
|---|---|
| Aug. 27, 2017 | 7th |
Bill Summary
(This measure has not been amended since it was passed by the House on July 12, 2017. The summary of that version is repeated here.) FDA Reauthorization Act of 2017 TITLE I--FEES RELATING TO DRUGS Prescription Drug User Fee Amendments of 2017 (Sec. 102) This bill amends the Federal Food, Drug, and Cosmetic Act to extend through FY2022 and revise Food and Drug Administration (FDA) user fees for brand name drugs. User fees are eliminated for...
(Source: Library of Congress)
Statement of Administration Policy
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
| Date | Description |
|---|---|
| Aug. 18, 2017 |
Became Public Law No: 115-52. |
| Aug. 18, 2017 |
Signed by President. |
| Aug. 7, 2017 |
Presented to President.
|
| Aug. 3, 2017 |
Message on Senate action sent to the House.
|
| Aug. 3, 2017 |
Vote in the SenatePassed Senate without amendment by Yea-Nay Vote. 94 - 1. Record Vote Number: 187. |
| Aug. 3, 2017 |
Measure laid before Senate by motion. (consideration: CR S4782-4787)
|
| Aug. 3, 2017 |
Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent.
|
| Aug. 3, 2017 |
Vote in the SenateCloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 96 - 1. Record Vote Number: 185. (CR S4787) |
| Aug. 3, 2017 |
Motion to proceed to measure considered in Senate.
|
| Aug. 1, 2017 |
Cloture motion on the motion to proceed to the measure presented in Senate. (CR S4663)
|
| Aug. 1, 2017 |
Motion to proceed to consideration of measure made in Senate. (CR S4663)
|
| July 17, 2017 |
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
|
| July 13, 2017 |
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
|
| July 12, 2017 |
Motion to reconsider laid on the table Agreed to without objection.
|
| July 12, 2017 |
Voice Vote in the HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5454-5477) |
| July 12, 2017 |
DEBATE - The House proceeded with forty minutes of debate on H.R. 2430.
|
| July 12, 2017 |
Considered under suspension of the rules. (consideration: CR H5454-5483)
|
| July 12, 2017 |
Mr. Walden moved to suspend the rules and pass the bill, as amended.
|
| July 11, 2017 |
Placed on the Union Calendar, Calendar No. 138.
|
| July 11, 2017 |
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-201.
|
| June 7, 2017 |
Ordered to be Reported (Amended) by the Yeas and Nays: 54 - 0.
|
| June 7, 2017 |
Committee Consideration and Mark-up Session Held.
|
| May 18, 2017 |
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
|
| May 18, 2017 |
Subcommittee Consideration and Mark-up Session Held.
|
| May 16, 2017 |
Referred to the Subcommittee on Health.
|
| May 16, 2017 |
Referred to the House Committee on Energy and Commerce.
|
| May 16, 2017 |
Introduced in the House by Greg Walden (R-Ore.) |